Juno Therapeutics Inc. (Nasdaq: JUNO) entered a 10-year, $1 billion
collaboration agreement with Celgene Corp. (Nasdaq: CELG). Shares of
Juno leaped $9.42 to $55.72 while Celgene stock edged up 3 cents to $114.94.
Juno collaborates with Celgene
June 30, 2015 at 12:01 PM EDT